TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8076921

Group type: EXPERIMENTAL
Intervention: Synthetic calcitonin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control treatment (less than one hundredth of the recommended dose of porcine calcitonin)
Number of subjects: 25
Study: 2676651

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg/day
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg/day + slow-release metoprolol 200 mg/day
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Chlorthalidone plus metoprolol
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Chlorthalidone plus metoprolol plus a third drug
Number of subjects: 545
Study: 356233

Group type: EXPERIMENTAL
Intervention: Antilymphocyte globulin (10 mg/kg body weight for a total of 25 times) in combination with prednisone and azathioprine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard regimen of prednisone and azathioprine
Number of subjects: 40
Study: 31187552

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (pelvic floor muscle exercises, bladder training, fluid and constipation management)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control condition (bladder diary self‐monitoring)
Number of subjects: 53
Study: 28214220

Group type: EXPERIMENTAL
Intervention: Hanging-drop technique in lateral recumbency (LHDo)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hanging-drop technique in sternal recumbency (SHDo)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Running-drip method (SRDi)
Number of subjects: 45
Study: 25797356

Group type: EXPERIMENTAL
Intervention: CPT‐11/CDDP (CPT‐11, 60 mg/m²; CDDP, 30 mg/m², q2w)
Number of subjects: 163

Group type: COMPARATOR
Intervention: CPT‐11 (150 mg/m², q2w)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: CPT‐11/CDDP
Number of subjects: 163

Group type: COMPARATOR
Intervention: CPT‐11
Number of subjects: 163
Study: 23590571

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (100 mg daily)
Number of subjects: 7000

Group type: EXPERIMENTAL
Intervention: L-selenomethionine (200 μg daily)
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 7000
Study: 21533333

Group type: EXPERIMENTAL
Intervention: Aerobic, strength and flexibility exercises for 24 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study: 19661114

Group type: EXPERIMENTAL
Intervention: Optimal left ventricular lead positions (LV‐Ps)
Number of subjects: 567
Study: 16756046

Group type: EXPERIMENTAL
Intervention: Counseling and clinical pathway for treatment of hypoglycemia
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional treatment for hypoglycemia
Number of subjects: 65
Study: 15365384

Group type: EXPERIMENTAL
Intervention: Uncorrected vision after 3 hours without refractive correction
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Grating acuity after 3 hours without refractive correction
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Refractive error measurement using noncycloplegic autorefraction
Number of subjects: 22
Study: 11726433

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 55

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 55
Study: 9427777

Group type: EXPERIMENTAL
Intervention: D-galactose (1.5 g/kg body weight per day)
Number of subjects: 193

Group type: COMPARATOR
Intervention: D-glucose containing electrolyte infusions (control group)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: D-galactose treatment
Number of subjects: 193
Study: 8302686

Group type: EXPERIMENTAL
Intervention: Piperacillin 4 g/70 kg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Mezlocillin 5 g/70 kg
Number of subjects: 9
Study: 3461023

Group type: EXPERIMENTAL
Intervention: Sodium monofluorophosphate dentifrice
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 7
Study: 29257028

Group type: EXPERIMENTAL
Intervention: Condoliase (1.25 U)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 27322401

Group type: EXPERIMENTAL
Intervention: NT-proBNP-guided therapy
Number of subjects: 271

Group type: COMPARATOR
Intervention: Control group (clinical evaluation alone)
Number of subjects: 271
Study: 24942277

Group type: EXPERIMENTAL
Intervention: S‐1 (80‐120 mg/day on days 1‐28 every 42 days; four courses)
Number of subjects: 1518

Group type: COMPARATOR
Intervention: UFT/LV (UFT: 300‐600 mg/day and LV: 75 mg/day on days 1‐28 every 35 days; five courses)
Number of subjects: 1518
Study: 21922164

Group type: EXPERIMENTAL
Intervention: Acculturation measured by SL‐ASIA
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Education in the US
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Younger age of arrival (0-5 years)
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Younger age of arrival (6-10 years)
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Self-identified as Americans
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Equal preference of Asian/American food in restaurants
Number of subjects: 847
Study: 20804245

Group type: EXPERIMENTAL
Intervention: Telephone-administered cognitive-behavioral therapy
Number of subjects: 127

Group type: COMPARATOR
Intervention: Telephone-administered supportive emotion focused therapy
Number of subjects: 127
Study: 18723437

Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg twice daily
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 16753969

Group type: EXPERIMENTAL
Intervention: riluzole
Number of subjects: 148
Study: 12830992

Group type: EXPERIMENTAL
Intervention: Valsartan (angiotensin II antagonist)
Number of subjects: 103
Study: 11956505

Group type: EXPERIMENTAL
Intervention: Voriconazole (200 mg every 12 hours)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 9591486

Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy, bone densitometry
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group (normal population)
Number of subjects: 241
Study: 7846209

Group type: EXPERIMENTAL
Intervention: Single morphine pretreatment (15 mg/70 kg IM)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Repeated morphine pretreatment (two doses of 15 mg/70 kg IM spaced 24 h apart)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Opioid abuse history
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonabusers
Number of subjects: 40
Study: 3411088

Group type: EXPERIMENTAL
Intervention: 5% spironolactone cream
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 6
Study: 31418989

Group type: EXPERIMENTAL
Intervention: yohimbine 54 mg + hydrocortisone 10 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: placebo (lactose 54 mg + lactose 10 mg)
Number of subjects: 21
Study: 31186388

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Custom foot orthotics (CFO)
Number of subjects: 83
Study: 27451294

Group type: EXPERIMENTAL
Intervention: 2 sachets of sodium picosulfate plus magnesium sulfate (P/MC)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 2 L of polyethylene glycol (PEG)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Clear fluids only
Number of subjects: 198
Study: 25808980

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham procedure (Control)
Number of subjects: 34
Study: 23506356

Group type: EXPERIMENTAL
Intervention: Monophasic cohesive polydensified matrix (CPM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Biphasic nonanimal stabilized hyaluronic acid (NASHA)
Number of subjects: 20
Study: 21679977

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy for prostate cancer
Number of subjects: 1244
Study: 18507878

Group type: EXPERIMENTAL
Intervention: Orange and blackcurrant juice (500 ml/d)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference beverage (sugar drink)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vitamin E (15 mg RRR-alpha-tocopherol/d)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Juice + Vitamin E
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Juice + Placebo
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference beverage + Vitamin E
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference beverage + Placebo
Number of subjects: 48
Study: 16430782

Group type: EXPERIMENTAL
Intervention: In situ care for pneumonia in nursing homes
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Decision-making involvement
Number of subjects: 14
Study: 15327191

Group type: EXPERIMENTAL
Intervention: Weight reduction program (Cigota)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 200
Study: 11535207

Group type: EXPERIMENTAL
Intervention: monophasic desogestrel/ethinylestradiol (DG/EE)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: triphasic levonorgestrel/ethinylestradiol (LNG/EE)
Number of subjects: 37
Study: 9407254

Group type: EXPERIMENTAL
Intervention: 6% glucose and fructose solution at a rate of approximately 60 g/hr
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (artificially flavored solution)
Number of subjects: 30
Study: 8218764

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MCP) 10 mg, three daily doses, vo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cinitapride (CTP) 1 mg, three daily doses, vo
Number of subjects: 20
Study: 3506191

Group type: EXPERIMENTAL
Intervention: Holding their own maternity case notes
Number of subjects: 246

Group type: COMPARATOR
Intervention: Standard co‐operation card
Number of subjects: 246
Study: 31927311

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) in the nucleus accumbens (NAcc)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) in the subgenual anterior cingulate cortex (subgenual ACC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Discontinuation of DBS
Number of subjects: 8

Group type: COMPARATOR
Intervention: Accidental switch off of DBS
Number of subjects: 8
Study: 31056776

Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 99

Group type: COMPARATOR
Intervention: 0 AADs
Number of subjects: 99

Group type: COMPARATOR
Intervention: 1 AAD
Number of subjects: 99

Group type: COMPARATOR
Intervention: ≥2 AADs
Number of subjects: 99
Study: 29196484

Group type: EXPERIMENTAL
Intervention: Samryungbaekchulsan (SRS) with Otilonium bromide (OB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo for Samryungbaekchulsan (SRS) with Otilonium bromide (OB)
Number of subjects: 80
Study: 26320838

Group type: EXPERIMENTAL
Intervention: Gait retraining
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: High-protein/low-glycaemic-index energy-restricted diet
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Combination of gait retraining, progressive resistance training, and high-protein/low-glycaemic-index diet
Number of subjects: 125

Group type: COMPARATOR
Intervention: Lifestyle-advice control group
Number of subjects: 125
Study: 23124784

Group type: EXPERIMENTAL
Intervention: Neutral-pH, low-glucose degradation product peritoneal dialysis fluids with 35 mM lactate
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Neutral-pH, low-glucose degradation product peritoneal dialysis fluids with 34 mM bicarbonate
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Lactate peritoneal dialysis fluid
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Bicarbonate peritoneal dialysis fluid
Number of subjects: 37
Study: 22104981

Group type: EXPERIMENTAL
Intervention: Armodafinil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19770284

Group type: EXPERIMENTAL
Intervention: Voriconazole (6 mg/kg q12h on day 1, then 4 mg/kg q12h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anidulafungin (200 mg on day 1, then 100 mg every 24 h)
Number of subjects: 20
Study: 16797271

Group type: EXPERIMENTAL
Intervention: 1 L of Belzer solution
Number of subjects: 43

Group type: COMPARATOR
Intervention: 2 L of Collins solution and 2 L of Belzer solution
Number of subjects: 43

Group type: COMPARATOR
Intervention: 3 L of Collins and 1 L of Belzer solution
Number of subjects: 43
Study: 15271637

Group type: EXPERIMENTAL
Intervention: Educational interventions about dementia diagnosis and management
Number of subjects: 127
Study: 10769856

Group type: EXPERIMENTAL
Intervention: 40% nitrous oxide/60% oxygen
Number of subjects: 22

Group type: COMPARATOR
Intervention: 100% oxygen
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Capnograph monitoring
Number of subjects: 22
Study: 9239770

Group type: EXPERIMENTAL
Intervention: MMRV and PedvaxHIB given concurrently
Number of subjects: 294

Group type: COMPARATOR
Intervention: M-M-R II and PedvaxHIB followed by VARIVAX 6 weeks later
Number of subjects: 294
Study: 8396101

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg/day for three days)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Co-amoxiclav (13.3 mg/kg tid for ten days)
Number of subjects: 389
Study: 2939870

Group type: EXPERIMENTAL
Intervention: Doxazosin 11.3 mg once daily
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Prazosin 13.8 mg twice daily
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172

Group type: COMPARATOR
Intervention: Doxazosin, Prazosin, and Placebo
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 172
Study: 31675478

Group type: EXPERIMENTAL
Intervention: H2-water (290 mL)
Number of subjects: 14
Study: 29405233

Group type: EXPERIMENTAL
Intervention: Crenezumab (anti-amyloid-β antibody)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Pre-screening process
Number of subjects: 252
Study: 25864681

Group type: EXPERIMENTAL
Intervention: Ethanol-based adhesive bond (ExciTEF, Ivoclar Vivadent) applied prior to sealant application
Number of subjects: 112

Group type: COMPARATOR
Intervention: No bonding agent used
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Patient's behaviour
Number of subjects: 112
Study: 25338555

Group type: EXPERIMENTAL
Intervention: Induction of labour at 41 + 0/+1 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expectant management until 42 weeks
Number of subjects: 0
Study: 24305423

Group type: EXPERIMENTAL
Intervention: Psoralen plus ultraviolet A (PUVA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Narrow band ultraviolet B (NB-UVB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 20
Study: 20605760

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery followed by chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serial assay of serum CA-125
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recent research protocols
Number of subjects: 0
Study: 18217460

Group type: EXPERIMENTAL
Intervention: Epidural clonidine before operation
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Peroral clonidine before operation
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Epidural clonidine at the end of the operation
Number of subjects: 91

Group type: COMPARATOR
Intervention: Epidural saline before operation
Number of subjects: 91
Study: 15277154

Group type: EXPERIMENTAL
Intervention: Low-glycemic-index diet (LGI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: High-glycemic-index diet (HGI)
Number of subjects: 45
Study: 11207173

Group type: EXPERIMENTAL
Intervention: Hypo-osmolar ORS (224 mmol/l)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard ORS (311 mmol/l)
Number of subjects: 64
Study: 10453599

Group type: EXPERIMENTAL
Intervention: Massage treatment for recurrent respiratory tract infection; details on dosage and duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (susceptible and healthy children); details on treatment not specified.
Number of subjects: 0
Study: 7872728

Group type: EXPERIMENTAL
Intervention: TGF-alpha expression in lung carcinomas
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: TGF-alpha expression
Number of subjects: 51
Study: 3207146

Group type: EXPERIMENTAL
Intervention: Cognitive skills remediation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive skills and ADL remediation program
Number of subjects: 0
Study: 30368472

Group type: EXPERIMENTAL
Intervention: Mechanical Thrombectomy (MT) in patients LSW >6 hours
Number of subjects: 752

Group type: COMPARATOR
Intervention: Mechanical Thrombectomy (MT) in patients LSW <6 hours
Number of subjects: 752
Study: 29635505

Group type: EXPERIMENTAL
Intervention: Intact whey protein (15 g)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hydrolyzed whey protein (15 g)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 11
Study: 27569684

Group type: EXPERIMENTAL
Intervention: Intravenous insulin infusion (hyperinsulinemic-euglycemic-clamp)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Intravenous saline infusion (control group)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both insulin and saline infusion groups
Number of subjects: 34
Study: 24865978

Group type: EXPERIMENTAL
Intervention: Transcutaneous electric acupoint stimulation
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 72
Study: 22927555

Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 6505

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6505
Study: 20707826

Group type: EXPERIMENTAL
Intervention: Home-visiting intervention for depressed mothers and their infants
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (untreated mother-child dyads)
Number of subjects: 58
Study: 17030438

Group type: EXPERIMENTAL
Intervention: TENS on four acupuncture points (Hegu [Li 4] and Sanyinjiao [Sp 6])
Number of subjects: 105

Group type: COMPARATOR
Intervention: TENS placebo
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: TENS group
Number of subjects: 105
Study: 15869351

Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Matched control participants
Number of subjects: 20
Study: 11919728

Group type: EXPERIMENTAL
Intervention: Thymoglobulin (2 mg/kg/day for 5 days before transplantation)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (no Thymoglobulin, similar regimen)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Thymoglobulin
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (no Thymoglobulin)
Number of subjects: 156
Study: 10598762

Group type: EXPERIMENTAL
Intervention: Serum levels of soluble E-selectin (sE-selectin) in untreated PPP patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Serum levels of TNF-alpha in untreated PPP patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Correlation between disease activity and serum levels of sE-selectin in untreated PPP patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Serum levels of sE-selectin in 10 PPP patients after treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Disease activity of PPP in smokers and during summer
Number of subjects: 30
Study: 7547057

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) administered during operation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 1936753

Group type: EXPERIMENTAL
Intervention: Acute administration of verapamil 160 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chronic treatment of verapamil 240 mg/day for six months
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6755325

Group type: EXPERIMENTAL
Intervention: Laminaria japonica
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study: 31852502

Group type: EXPERIMENTAL
Intervention: Intervention group (evidence-based groups delivered by trained staff)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 27696633

Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulative therapy (CSMT)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Placebo (sham push manoeuvre)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (usual pharmacological management)
Number of subjects: 104
Study: 26432128

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate 0.1% and carboxymethylcellulose 0.5% artificial tears
Number of subjects: 282

Group type: COMPARATOR
Intervention: Topical steroid-antibiotic alone
Number of subjects: 282
Study: 23567660

Group type: EXPERIMENTAL
Intervention: Maximum of 4 electrode pairs activated (Group 1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Maximum of 2 electrode pairs activated (Group 2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group 1
Number of subjects: 120

Group type: COMPARATOR
Intervention: Group 2
Number of subjects: 120
Study: 21332825

Group type: EXPERIMENTAL
Intervention: Propiverine (20 mg once daily)
Number of subjects: 567

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 567
Study: 19184182

Group type: EXPERIMENTAL
Intervention: 12-lead EKG
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Holter studies
Number of subjects: 457

Group type: COMPARATOR
Intervention: Risk factors
Number of subjects: 457

Group type: COMPARATOR
Intervention: Umbilical venous lines and dopamine infusion
Number of subjects: 457
Study: 18091666

Group type: EXPERIMENTAL
Intervention: Guided‐tissue regeneration therapy (GTR) with scaling and root planing (SRP) and application of a bioresorbable membrane
Number of subjects: 11

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 11
Study: 15457806

Group type: EXPERIMENTAL
Intervention: 6-digit load
Number of subjects: 0

Group type: COMPARATOR
Intervention: no-load control
Number of subjects: 0
Study: 11840580

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg i.v.
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Dexamethasone 5 mg i.v.
Number of subjects: 135

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 135
Study: 9500689

Group type: EXPERIMENTAL
Intervention: ursodeoxycholic acid (UDCA) 23-25 mg/kg/d
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg/d
Number of subjects: 14

Group type: COMPARATOR
Intervention: UDCA
Number of subjects: 14

Group type: COMPARATOR
Intervention: simvastatin
Number of subjects: 14